Literature DB >> 975640

Defective human mononuclear leukocyte chemotaxis as an index of host resistance to malignant melanoma.

R H Rubin, A B Cosimi, E J Goetzl.   

Abstract

Entities:  

Mesh:

Year:  1976        PMID: 975640     DOI: 10.1016/0090-1229(76)90091-x

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


× No keyword cloud information.
  13 in total

1.  Serum associated leucocyte locomotion inhibition and leucocyte motility in malignant melanoma: effect of BCG treatment.

Authors:  C Zielinski; H Pehamberger; A T Endler; W Knapp
Journal:  Clin Exp Immunol       Date:  1979-10       Impact factor: 4.330

Review 2.  Disordered function of mononuclear phagocytes in malignant disease.

Authors:  R J Sokol; G Hudson
Journal:  J Clin Pathol       Date:  1983-03       Impact factor: 3.411

3.  Normalization of defective monocyte chemotaxis during chemotherapy in patients with small cell anaplastic carcinoma of the lung.

Authors:  H Nielsen; J Bennedsen; P Dombernowsky
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Monocyte responsiveness to chemotactic stimuli is a property of a subpopulation of cells that can respond to multiple chemoattractants.

Authors:  G J Cianciolo; R Snyderman
Journal:  J Clin Invest       Date:  1981-01       Impact factor: 14.808

Review 5.  Effects of tumor growth on host defenses.

Authors:  G J Cianciolo; R Snyderman
Journal:  Cancer Metastasis Rev       Date:  1986       Impact factor: 9.264

6.  A quantitative and qualitative study of blood monocytes in patients with bronchogenic carcinoma.

Authors:  H Nielsen; J Bennedsen; S O Larsen; P Dombernowsky; K Viskum
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

7.  Macrophage migratory dysfunction in cancer. A mechanism for subversion of surveillance.

Authors:  R Snyderman; M C Pike
Journal:  Am J Pathol       Date:  1977-09       Impact factor: 4.307

8.  Effect of autologous and homologous serum and circulating immune complexes on monocyte functions of patients with solid tumours.

Authors:  A Celada; T Aguado; P H Lambert; A Cruchaud
Journal:  Clin Exp Immunol       Date:  1980-08       Impact factor: 4.330

9.  In vitro monocyte maturation as a prediction of survival in squamous cell carcinoma of the lung.

Authors:  R G Dent; P Cole
Journal:  Thorax       Date:  1981-06       Impact factor: 9.139

10.  Defective monocyte chemotactic responsiveness in patients with multiple myeloma and benign monoclonal gammapathy.

Authors:  F Dammacco; A Miglietta; M T Ventura; L Bonomo
Journal:  Clin Exp Immunol       Date:  1982-02       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.